Page 105 - FINAL PROGRAMME 2017

TUESDAY, 4 JULY 2017
SELECTED ORAL COMMUNICATIONS
10:00 - 11:30 Room B
Session 35: Oocytes, donors and outcomes
Chairman: F. Shen eld (United Kingdom) Chairman: Chairman to be announced
10:00 O-122
Quantifying the parameters affecting the success of egg donor program: a predictive model and optimization tool
M. Calonge1, N. Garrido2, A. Cobo3, F. Gonzalez-Valdes4, D. Morbeck5, A. Requena6, C. Troncoso7 1IVI Santiago, IVF Laboratory, Santiago, Chile
2IVI Valencia, Andrology Laboratory and Sperm Bank, Valencia, Spain
3IVI Valencia, IVF Laboratory, Valencia, Spain
4Ponti cia Universidad Catolica de Chile, Engineering, Santiago, Chile 5Mayo Clinic, IVF Laboratory, Rochester, U.S.A.
6IVI Madrid, Gynecology, Madrid, Spain
7IVI Santiago, Gynecology, Santiago, Chile
Perinatal outcomes following gestational surrogacy versus autologous IVF: analysis of 87,815 singleton live births
S.K. Sunkara1, B. Antonisamy2, M.S. Kamath3
1Queen's Hospital, Assisted Conception Unit, Essex, United Kingdom 2Christian Medical College, Department of Biostatistics, Vellore, India 3Christian Medical College, Reproductive Medicine Unit, Vellore, India
Shared motherhood: high delivery rates in a large series of egg donation treatments for lesbian couples using partner-donated eggs
D. Bodri1, S. Nair1, A. Gill1, G. Lamanna1, M. Rahmati1, M. Arian-Schad1, V. Smith1, E. Linara1, J. Wang1, K. Ahuja1
1London Women's Clinic, Assisted Reproduction, London, United Kingdom
Oocyte donation in women cured from cancer provide similar live birth rates compared to women without previous history of cancer
M. Zanette1, D. García2, R. Vassena1, A. Rodríguez1 1Clínica EUGIN, EUGIN, Barcelona, Spain 2Fundación EUGIN, EUGIN, Barcelona, Spain
10:15 O-123
10:30 O-124
10:45 O-125
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 105
SCIENTIFIC PROGRAMME TUESDAY, 4 JULY